In the event of an inadvertent temperature excursion the following data may be used:
A maximum cumulative time of 168 hours is permitted for the vaccine to be at temperatures above 8°C through to 25°C.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk.
Contact GSK in cases where the product has been exposed to temperature deviation other than described above. Refer to the current BNF for company contact details.

In the event of an inadvertent temperature excursion the following data may be used:
A maximum cumulative time of 168 hours is permitted for the vaccine to be at temperatures above 8°C through to 25°C.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk.
Contact GSK in cases where the product has been exposed to temperature deviation other than described above. Refer to the current BNF for company contact details.